3873
CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or venlafaxine when metoclopramide is coadministered even in a single , conventional dose .
 adverse effect: extrapyramidal reactions, metoclopramide; adverse effect: extrapyramidal reactions, sertraline; adverse effect: extrapyramidal reactions, venlafaxine; adverse effect: serotonin syndrome, metoclopramide; adverse effect: serotonin syndrome, sertraline; adverse effect: serotonin syndrome, venlafaxine
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  extrapyramidal reactions, metoclopramide; extrapyramidal reactions, sertraline; extrapyramidal reactions, venlafaxine; serotonin syndrome, metoclopramide; serotonin syndrome, sertraline; serotonin syndrome, venlafaxine 
Answer:
 adverse effect: extrapyramidal reactions, metoclopramide; adverse effect: extrapyramidal reactions, sertraline; adverse effect: extrapyramidal reactions, venlafaxine; adverse effect: serotonin syndrome, metoclopramide; adverse effect: serotonin syndrome, sertraline; adverse effect: serotonin syndrome, venlafaxine